These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 33465114)
1. Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin. Faruk M; Ibrahim S; Aminu SM; Adamu A; Abdullahi A; Suleiman AM; Rafindadi AH; Mohammed A; Iliyasu Y; Idoko J; Saidu R; Randawa AJ; Musa HS; Ntekim A; Shah KZ; Abubakar S; Adoke KU; Manko M; Awasum CA PLoS One; 2021; 16(1):e0245581. PubMed ID: 33465114 [TBL] [Abstract][Full Text] [Related]
2. Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma. Guo J; Yu Z; Sun D; Zou Y; Liu Y; Huang L Mol Cancer; 2021 Jan; 20(1):10. PubMed ID: 33407548 [TBL] [Abstract][Full Text] [Related]
3. Expression of the apoptosis repressor with caspase recruitment domain (ARC) in liver metastasis of colorectal cancer and its correlation with DNA mismatch repair proteins and p53. Tóth C; Meinrath J; Herpel E; Derix J; Fries J; Buettner R; Schirmacher P; Heikaus S J Cancer Res Clin Oncol; 2016 May; 142(5):927-35. PubMed ID: 26721253 [TBL] [Abstract][Full Text] [Related]
4. Mismatch repair protein expression is an independent prognostic factor in sporadic colorectal cancer. Ohrling K; Edler D; Hallström M; Ragnhammar P Acta Oncol; 2010 Aug; 49(6):797-804. PubMed ID: 20307245 [TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive significance of long interspersed nucleotide element-1 methylation in advanced-stage colorectal cancer. Kaneko M; Kotake M; Bando H; Yamada T; Takemura H; Minamoto T BMC Cancer; 2016 Dec; 16(1):945. PubMed ID: 27955637 [TBL] [Abstract][Full Text] [Related]
6. Mechanistic analysis and comparison of viral fusogenic membrane proteins for their synergistic effects on chemotherapy. Hoffmann D; Grunwald T; Kuate S; Wildner O Cancer Biol Ther; 2007 Apr; 6(4):510-8. PubMed ID: 17374986 [TBL] [Abstract][Full Text] [Related]
7. Identification of Two Subgroups of FOLFOX Resistance Patterns and Prediction of FOLFOX Response in Colorectal Cancer Patients. Tian S; Wang F; Lu S; Chen G Cancer Invest; 2021 Jan; 39(1):62-72. PubMed ID: 33258714 [TBL] [Abstract][Full Text] [Related]
8. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters. Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545 [TBL] [Abstract][Full Text] [Related]
9. Effect of preoperative FOLFOX chemotherapy on CCL20/CCR6 expression in colorectal liver metastases. Rubie C; Frick VO; Ghadjar P; Wagner M; Justinger C; Graeber S; Sperling J; Kollmar O; Schilling MK World J Gastroenterol; 2011 Jul; 17(26):3109-16. PubMed ID: 21912453 [TBL] [Abstract][Full Text] [Related]
10. Aspirin-induced nuclear translocation of NFkappaB and apoptosis in colorectal cancer is independent of p53 status and DNA mismatch repair proficiency. Din FV; Stark LA; Dunlop MG Br J Cancer; 2005 Mar; 92(6):1137-43. PubMed ID: 15770215 [TBL] [Abstract][Full Text] [Related]
11. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers]. Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605 [No Abstract] [Full Text] [Related]
12. Lipid core-shell nanoparticles co-deliver FOLFOX regimen and siPD-L1 for synergistic targeted cancer treatment. Cao W; Zhang X; Li R; Li Z; Lu A; Yu F; Sun L; Wang J; Wang Z; He H J Control Release; 2024 Apr; 368():52-65. PubMed ID: 38368946 [TBL] [Abstract][Full Text] [Related]
13. Detection of DNA Mismatch Repair Protein Abnormalities in Sudanese Colorectal Cancer Patients Using Immunohistochemical Methods. Zakout YM; Lanza G J Gastrointest Cancer; 2019 Sep; 50(3):530-536. PubMed ID: 29850986 [TBL] [Abstract][Full Text] [Related]
14. N-myc downstream-regulated gene 1 promotes oxaliplatin-triggered apoptosis in colorectal cancer cells via enhancing the ubiquitination of Bcl-2. Yang X; Zhu F; Yu C; Lu J; Zhang L; Lv Y; Sun J; Zheng M Oncotarget; 2017 Jul; 8(29):47709-47724. PubMed ID: 28537875 [TBL] [Abstract][Full Text] [Related]
15. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy. Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812 [TBL] [Abstract][Full Text] [Related]
16. Early effects of FOLFOX treatment of colorectal tumour in an animal model: assessment of changes in gene expression and FDG kinetics. Strauss LG; Hoffend J; Koczan D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1226-34. PubMed ID: 19280186 [TBL] [Abstract][Full Text] [Related]
17. Fecal Microbiota Transplantation Prevents Intestinal Injury, Upregulation of Toll-Like Receptors, and 5-Fluorouracil/Oxaliplatin-Induced Toxicity in Colorectal Cancer. Chang CW; Lee HC; Li LH; Chiang Chiau JS; Wang TE; Chuang WH; Chen MJ; Wang HY; Shih SC; Liu CY; Tsai TH; Chen YJ Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936237 [TBL] [Abstract][Full Text] [Related]
18. FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms. Lu W; Fu D; Kong X; Huang Z; Hwang M; Zhu Y; Chen L; Jiang K; Li X; Wu Y; Li J; Yuan Y; Ding K Cancer Med; 2020 Feb; 9(4):1419-1429. PubMed ID: 31893575 [TBL] [Abstract][Full Text] [Related]
19. Systems biology analysis identifies molecular determinants of chemotherapy-induced diarrhoea. Lindner AU; Resler AJ; Carberry S; Oficjalska K; Bacon O; Lee CS; Choudhry A; Burke JP; Sheahan K; Cremona M; Hennessy BT; McNamara D; Doherty G; Ryan EJ; Prehn JHM J Mol Med (Berl); 2020 Jan; 98(1):149-159. PubMed ID: 31848663 [TBL] [Abstract][Full Text] [Related]
20. Erk Inhibition as a Promising Therapeutic Strategy for High IL-8-Secreting and Low SPTAN1-Expressing Colorectal Cancer. Meier C; La Rocca G; Nawrot V; Fißlthaler B; Overby SJ; Hourfar K; Plotz G; Seidl C; Ziegler P; Wild P; Zeuzem S; Brieger J; Jäger E; Battmann A; Brieger A Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]